[Interstitial brachytherapy using 192-iridium in locally recurring tumors].
Between January 1983 and December 1985 49 patients with different malignancies underwent a palliative interstitial brachytherapy with 192Iridium. 25 patients with local recurrences without distant metastases were analysed retrospectively: 17 (68%) complete remissions and six (24%) partial remissions were achieved, two (8%) patients did not respond to therapy. Seven patients (28%) developed subsequent recurrence.
Schmid
A P
AP
Universitätsklinik für Strahlentherapie und Strahlenbiologie Wien.
D000230:Adenocarcinoma / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D001005:Anus Neoplasms / Q000532:radiotherapy; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D012004:Rectal Neoplasms / Q000532:radiotherapy
D007496:Iridium Radioisotopes
Die interstitielle Brachytherapie mit 192Iridium bei lokal rezidivierenden Tumoren.